[Form 4] NATIONAL HEALTHCARE CORP Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
National Healthcare Corp. (NHC) CEO and director Stephen Flatt reported insider transactions on 11/11/2025. He exercised 3,000 options at $94.10 per share (code M) and the company withheld 2,480 shares to cover the exercise price and taxes (code F). Following these transactions, he beneficially owns 60,130 common shares.
Outstanding equity awards listed include options expiring on 03/08/2028 at $53.94 (8,000 shares), on 03/05/2029 at $94.10 (10,000 shares after the exercise), and on 02/28/2030 at $90.62 (18,000 shares).
Positive
- None.
Negative
- None.
Insider Trade Summary
3,000 shares exercised/converted
Mixed
5 txns
Insider
Flatt Stephen Fowler
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock | 3,000 | $0.00 | -- |
| Exercise | Common Stock | 3,000 | $94.10 | $282K |
| Tax Withholding | Common Stock | 2,480 | $132.20 | $328K |
| holding | Option to Purchase Common Stock | -- | -- | -- |
| holding | Option to Purchase Common Stock | -- | -- | -- |
Holdings After Transaction:
Option to Purchase Common Stock — 10,000 shares (Direct);
Common Stock — 62,610 shares (Direct)
Footnotes (1)
- These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.
FAQ
What did NHC’s CEO report in this Form 4?
He exercised 3,000 options at $94.10 and 2,480 shares were withheld to cover the exercise price and taxes.
What is the date of the reported transactions for NHC (NHC)?
The transactions occurred on 11/11/2025.
Which transaction codes were used in the filing?
Code M for option exercise and code F for share withholding to cover price and taxes.
What option grants remain outstanding for the reporting person?
Options include $53.94 expiring 03/08/2028 (8,000), $94.10 expiring 03/05/2029 (10,000), and $90.62 expiring 02/28/2030 (18,000).
Under which plan were the options granted?
They were granted under the 2020 Omnibus Equity Incentive Plan.